OSUR News and Press, OraSure Technologies Inc. From 11/03/22

FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of...

BETHLEHEM, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 Rapid Test is now available in Amazon’s...

BETHLEHEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, November 8, 2022. Nove...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The traditional definition of penny stocks is those companies whose shares trade for $5 or less. It’s never easy finding cheap penny stocks to buy amongst this oppressed group because they are often selling at a low...

OraSure Technologies, Inc. ( NASDAQ: OSUR ), a developer of diagnostic products, announced Wednesday that the Biomedical Advanced Research and Development Authority (BARDA) awarded the company an $8.6M contract to develop a 2nd generation Ebola test. OSUR has won the FDA&#...

BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Biomedical Advanced Research and Development Authority (BARDA) has issued t...

BETHLEHEM, Pa., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Company has been selected to provide its OraQuick ® In-Home HIV te...

BETHLEHEM, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure Technologies, ...

Summary OraSure continues to present with caution now that the company's revenue mix remains tilted to Covid-19. With future cash flows set to diminish alongside Covid-19 testing volumes, OSUR's core business needs to step up to the forefront. This hasn't happened to date, how...

The federal government's program of providing free at-home COVID-19 tests sent by mail will end on Sept. 2 due to a lack of funding, NBC News reported. The covid.gov website states that the program will end on that date as "Congress hasn't provided additional funding to re...